Medication-Assisted Treatment

Helping to End Addiction Long-Term Initiative by NIH Launched to Address Opioid Epidemic

Helping to End Addiction Long-Term Initiative by NIH Launched to Address Opioid Epidemic

By

National Institutes of Health Director, Francis Collins, MD, PhD, announced on April 4, 2018 the launch of the Helping to End Addiction Long-Term Initiative.

FDA Approves Once-Monthly Buprenorphine Injection for Opioid Use Disorder

FDA Approves Once-Monthly Buprenorphine Injection for Opioid Use Disorder

By

In a press release issued November 30, 2017, the US Food and Drug Administration announced it has approved Sublocade, a once-monthly buprenorphine injection for moderate to severe opioid use disorder.

Opioid Use Disorder Treatment in Teens

Opioid Use Disorder Treatment in Teens

By

Only a small percentage of adolescents undergoing treatment for severe opioid use disorders are receiving medication therapy to manage their condition.

Sign Up for Free e-Newsletters